Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

被引:0
|
作者
Laura Schirosi
Sabino Strippoli
Francesca Gaudio
Giusi Graziano
Ondina Popescu
Michele Guida
Giovanni Simone
Anita Mangia
机构
[1] IRCCS Istituto Tumori “Giovanni Paolo II”,Functional Biomorphology Laboratory
[2] IRCCS Istituto Tumori “Giovanni Paolo II”,Medical Oncology Department
[3] IRCCS Istituto Tumori “Giovanni Paolo II”,Scientific Direction
[4] IRCCS Istituto Tumori “Giovanni Paolo II”,Pathology Department
来源
BMC Cancer | / 16卷
关键词
Melanoma; BRAF; VE1; Immunohistochemistry; Progression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
    Chong Sun
    Liqin Wang
    Sidong Huang
    Guus J. J. E. Heynen
    Anirudh Prahallad
    Caroline Robert
    John Haanen
    Christian Blank
    Jelle Wesseling
    Stefan M. Willems
    Davide Zecchin
    Sebastijan Hobor
    Prashanth K. Bajpe
    Cor Lieftink
    Christina Mateus
    Stephan Vagner
    Wipawadee Grernrum
    Ingrid Hofland
    Andreas Schlicker
    Lodewyk F. A. Wessels
    Roderick L. Beijersbergen
    Alberto Bardelli
    Federica Di Nicolantonio
    Alexander M. M. Eggermont
    Rene Bernards
    Nature, 2014, 508 : 118 - 122
  • [42] BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Del Bufalo, Francesca
    Ceglie, Giulia
    Cacchione, Antonella
    Alessi, Iside
    Colafati, Giovanna Stefania
    Carai, Andrea
    Diomedi-Camassei, Francesca
    De Billy, Emmanuel
    Agolini, Emanuele
    Mastronuzzi, Angela
    Locatelli, Franco
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [43] Prospective immunohistochemical analysis of BRAF V600E mutation in melanoma
    Thiel, Alexandra
    Moza, Monica
    Kytola, Soili
    Orpana, Arto
    Jahkola, Tiina
    Hernberg, Micaela
    Virolainen, Susanna
    Ristimaki, Ari
    HUMAN PATHOLOGY, 2015, 46 (02) : 169 - 175
  • [44] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    Chapman, Paul B.
    Hauschild, Axel
    Robert, Caroline
    Haanen, John B.
    Ascierto, Paolo
    Larkin, James
    Dummer, Reinhard
    Garbe, Claus
    Testori, Alessandro
    Maio, Michele
    Hogg, David
    Lorigan, Paul
    Lebbe, Celeste
    Jouary, Thomas
    Schadendorf, Dirk
    Ribas, Antoni
    O'Day, Steven J.
    Sosman, Jeffrey A.
    Kirkwood, John M.
    Eggermont, Alexander M. M.
    Dreno, Brigitte
    Nolop, Keith
    Li, Jiang
    Nelson, Betty
    Hou, Jeannie
    Lee, Richard J.
    Flaherty, Keith T.
    McArthur, Grant A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26): : 2507 - 2516
  • [45] Multifocal BRAF(V600E)-Mutated Melanoma in situ on the Foot
    Iwama, Eimei
    Fujimura, Taku
    Kusakari, Yoshiyuki
    Haga, Takahiro
    Aiba, Setsuya
    CASE REPORTS IN DERMATOLOGY, 2015, 7 (03): : 322 - 327
  • [46] Braf V600E mutation in melanoma: translational current scenario
    J. A. Guadarrama-Orozco
    A. Ortega-Gómez
    E. B. Ruiz-García
    H. Astudillo-de la Vega
    A. Meneses-García
    C. Lopez-Camarillo
    Clinical and Translational Oncology, 2016, 18 : 863 - 871
  • [47] V600E BRAF Mutation in Vulvovaginal Melanoma Is Rare: A Study of Anti-Human BRAF V600E Monoclonal Antibody in 24 Cases
    Ramineni, M.
    Malpica, A.
    Luthra, R.
    Deavers, M. T.
    Euscher, E. D.
    MODERN PATHOLOGY, 2013, 26 : 293A - 293A
  • [48] The safety and efficacy of cobimetinib for the treatment of BRAF V600E or V600K melanoma
    Amaral, Teresa
    Nouri, Noura
    Garbe, Claus
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (07) : 705 - 715
  • [49] V600E BRAF Mutation in Vulvovaginal Melanoma Is Rare: A Study of Anti-Human BRAF V600E Monoclonal Antibody in 24 Cases
    Ramineni, M.
    Malpica, A.
    Luthra, R.
    Deavers, M. T.
    Euscher, E. D.
    LABORATORY INVESTIGATION, 2013, 93 : 293A - 293A
  • [50] EGFR Expression and V600E BRAF Mutations Influence Disease Progression in Thyroid Carcinoma
    Fisher, K. E.
    Hill, C. E.
    Foulks, C.
    Weber, C. J.
    Sharma, J.
    Cohen, C.
    LABORATORY INVESTIGATION, 2012, 92 : 143A - 144A